bezafibrate has been researched along with Glomerulonephritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, CC; Lee, YT; Su, TC; Yang, KC | 1 |
| Ajiro, J; Gejyo, F; Kaneko, Y; Kondo, D; Kuroda, T; Miida, T; Narita, I; Ogawa, A; Saga, D; Sakatsume, M; Sato, F; Tsubata, Y | 1 |
2 other study(ies) available for bezafibrate and Glomerulonephritis
| Article | Year |
|---|---|
Treatment of fibrate-induced rhabdomyolysis with plasma exchange in ESRD.
Topics: Bezafibrate; Combined Modality Therapy; Female; Glomerulonephritis; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Kidney Failure, Chronic; Middle Aged; Plasma Exchange; Renal Dialysis; Rhabdomyolysis | 2005 |
Bezafibrate suppresses rat antiglomerular basement membrane crescentic glomerulonephritis.
Topics: Animals; Antibodies; Basement Membrane; Bezafibrate; Glomerulonephritis; Kidney Glomerulus; Lymphocyte Activation; Male; PPAR alpha; Rabbits; Rats; Rats, Inbred WKY; Time Factors | 2005 |